09th week of 2020 patent applcation highlights part 28 |
Patent application number | Title | Published |
20200062767 | SUBSTITUTED PYRROLIDINYL AND PIPERIDINYL PYRAZOLOPYRIDAZINE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN | 2020-02-27 |
20200062768 | CX3CR1 Small Molecule Antagonists, and Methods Using Same | 2020-02-27 |
20200062769 | HETEROARYL PYRIDONE AND AZA-PYRIDONE COMPOUNDS | 2020-02-27 |
20200062770 | PDE9 INHIBITORS WITH IMIDAZO TRIAZINONE BACKBONE AND IMIDAZO PYRAZINONE BACKBONE FOR TREATMENT OF PERIPHERAL DISEASES | 2020-02-27 |
20200062771 | POTENT AGELASTATIN DERIVATIVES AS MODULATORS FOR CANCER INVASION AND METASTASIS | 2020-02-27 |
20200062772 | PROCESS FOR PREPARING OXYCODONE COMPOSITIONS | 2020-02-27 |
20200062773 | 4,4a,5,7-TETRAHYDRO-3H-FURO[3,4-b]PYRIDINYL COMPOUNDS | 2020-02-27 |
20200062774 | METHOD OF PREPARING D-GLUCARO-1,4:6,3-DILACTONE | 2020-02-27 |
20200062775 | IRAK4 INHIBITOR AND USE THEREOF | 2020-02-27 |
20200062776 | HEDGEHOG ACYLTRANSFERASE INHIBITORS AND USES THEREOF | 2020-02-27 |
20200062777 | THIENOPYRIDINES AND BENZOTHIOPHENES USEFUL AS IRAK4 INHIBITORS | 2020-02-27 |
20200062778 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | 2020-02-27 |
20200062779 | THERAPEUTIC COMPOUNDS AND COMPOSITIONS, AND METHODS OF USE THEREOF | 2020-02-27 |
20200062780 | COMPOUNDS THAT INHIBIT MCL-1 PROTEIN | 2020-02-27 |
20200062781 | BISARYL HETEROCYCLES AS NRF2 ACTIVATORS | 2020-02-27 |
20200062782 | BIFUNCTIONAL ALPHA-SYNUCLEIN BINDING AGENTS AND USES THEREOF | 2020-02-27 |
20200062783 | PHOTO LEWIS ACID GENERATOR | 2020-02-27 |
20200062784 | BIOREDUCIBLE N-OXIDE-BASED PROBES FOR IMAGING OF HYPOXIA | 2020-02-27 |
20200062785 | NOVEL PROCESS FOR THE PREPARATION OF 4-[(1-HYDROXY-1,3-DIHYDRO-2,1-BENZOXABOROL-5-YL) OXY] BENZONITRILE (CRISABOROLE) | 2020-02-27 |
20200062786 | PROCESS FOR THE MANUFACTURING OF TRIARYL-ORGANO BORATES | 2020-02-27 |
20200062787 | Stable Alkenyl Or Alkynyl-Containing Organosilicon Precursor Compositions | 2020-02-27 |
20200062788 | HYDROXYAPATITE JANUS PARTICLES | 2020-02-27 |
20200062789 | HYDROXAMIC ACID PRODRUG COMPOUND OR SALT THEREOF, LYOPHILIZED FORMULATION, LPXC INHIBITOR, AND ANTIBACTERIAL AGENT | 2020-02-27 |
20200062790 | ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS | 2020-02-27 |
20200062791 | MANGANESE CHELATE COMPOUNDS | 2020-02-27 |
20200062792 | HIGH-PURITY D-PSICOSE PREPARATION METHOD | 2020-02-27 |
20200062793 | APRAMYCIN DERIVATIVES | 2020-02-27 |
20200062794 | METHOD FOR PRODUCING SUGAR HAVING SULFATE GROUP AND/OR PHOSPHATE GROUP | 2020-02-27 |
20200062795 | SUBSTITUTED 4-PHENYL PYRIDINE COMPOUNDS AS NON-SYSTEMIC TGR5 AGONISTS | 2020-02-27 |
20200062796 | METHOD FOR PRODUCING FLAVONOID INCLUSION COMPOUND | 2020-02-27 |
20200062797 | INHIBITORS OF CD73-MEDIATED IMMUNOSUPPRESSION | 2020-02-27 |
20200062798 | CYCLIC DI-NUCLEOTIDE COMPOUNDS AS STING AGONISTS | 2020-02-27 |
20200062799 | IMMUNE MODULATORY COMPOSITIONS | 2020-02-27 |
20200062800 | 2,2-DIFLUOROPROPIONAMIDE DERIVATIVES OF BARDOXOLONE METHYL, POLYMORPHIC FORMS AND METHODS OF USE THEREOF | 2020-02-27 |
20200062801 | EPIMERIZATION-FREE N TO C SOLID-PHASE PEPTIDE SYNTHESIS | 2020-02-27 |
20200062802 | Use of Raman Spectroscopy in Downstream Purification | 2020-02-27 |
20200062803 | AZAINDOLINE COMPOUNDS AS GRANZYME B INHIBITORS | 2020-02-27 |
20200062804 | PEPTIDE INHIBITORS OF TRANSCRIPTION FACTOR AGGREGATION | 2020-02-27 |
20200062805 | Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway | 2020-02-27 |
20200062806 | NOVEL PEPTIDES AND THEIR USE IN DIAGNOSIS | 2020-02-27 |
20200062807 | PROTEOLYTIC INACTIVATION OF SELECT PROTEINS IN BACTERIAL EXTRACTS FOR IMPROVED EXPRESSION | 2020-02-27 |
20200062808 | PEPTIDES AND COMPOSITIONS FOR PREVENTION OF CELL ADHESION AND METHODS OF USING SAME | 2020-02-27 |
20200062809 | METHOD FOR SEPARATING AND PURIFYING MUSSEL ADHESIVE PROTEIN | 2020-02-27 |
20200062810 | IMMUNOSTIMULATING COMPOSITIONS AND USES THEREFORE | 2020-02-27 |
20200062811 | YAP PROTEIN INHIBITING POLYPEPTIDE AND APPLICATION THEREOF | 2020-02-27 |
20200062812 | NUCLEIC ACID ENCODING GENETICALLY ENGINEERED GROWTH FACTOR VARIANTS | 2020-02-27 |
20200062813 | Improved Loading of EVs with Therapeutic Proteins | 2020-02-27 |
20200062814 | Modified Latency Associated Protein Construct | 2020-02-27 |
20200062815 | COMPOSITIONS INCLUDING DIFFERENT TYPES OF TRANSFER FACTOR | 2020-02-27 |
20200062816 | IL-31 Improves Efficacy of Macrophage-Based Adoptive Cell Therapy for Cancer | 2020-02-27 |
20200062817 | CRETION-COMPETENT MUTEINS OF THE HUMAN IL-27 ALPHA-SUBUNIT | 2020-02-27 |
20200062818 | BIFUNCTIONAL FUSION PROTEINS TO INHIBIT ANGIOGENESIS IN TUMOR MICROENVIRONMENT AND TO ACTIVATE ADAPTIVE IMMUNE RESPONSES AND THE GENES AND USES THEREOF | 2020-02-27 |
20200062819 | PEPTIDE-MHC COMPACTS | 2020-02-27 |
20200062820 | Method for Treating Ischemic Tissue | 2020-02-27 |
20200062821 | Ca2+ REGULATED BINDING AGENTS | 2020-02-27 |
20200062822 | ANTI-TNF-ALPHA POLYPEPTIDE COMPOSITION AND USE THEREOF | 2020-02-27 |
20200062823 | COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING PATHOGENIC FUNGAL INFECTION AND FOR MAINTENANCE OF MICROBIOME COMMENSALISM | 2020-02-27 |
20200062824 | STABILIZED FIBRONECTIN BASED SCAFFOLD MOLECULES | 2020-02-27 |
20200062825 | GENERATION OF HEMOGLOBIN-BASED OXYGEN CARRIERS USING ELASTIN-LIKE POLYPEPTIDES | 2020-02-27 |
20200062826 | TRIVALENT, BISPECIFIC ANTIBODIES | 2020-02-27 |
20200062827 | A SUPRAMOLECULAR HIGH AFFINITY PROTEIN-BINDING SYSTEM FOR PURIFICATION OF BIOMACROMOLECULES | 2020-02-27 |
20200062828 | ANTIBODY CAPABLE OF BINDING TO NOROVIRUS, COMPOSITE, DETECTION DEVICE AND METHOD USING THE SAME | 2020-02-27 |
20200062829 | ANTIBODY CAPABLE OF BINDING TO NOROVIRUS, COMPOSITE, DETECTION DEVICE AND METHOD USING THE SAME | 2020-02-27 |
20200062830 | FLAVIVIRUS NEUTRALIZING ANTIBODIES AND METHODS OF USE THEREOF | 2020-02-27 |
20200062831 | Anti-Zika Virus Antibodies and Methods of Use | 2020-02-27 |
20200062832 | DbpA ANTIBODIES AND USES THEREOF | 2020-02-27 |
20200062833 | VHH-CONTAINING HEAVY CHAIN ANTIBODY AND PRODUCTION THEREOF | 2020-02-27 |
20200062834 | METHOD FOR THE PRODUCTION OF IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS | 2020-02-27 |
20200062835 | Monoclonal Antibodies Against Alpha-Synuclein Fibrils | 2020-02-27 |
20200062836 | THERAPY FOR METATASTIC COLORECTAL CANCER USING ANTI-VEGFR-2 and ANTI-VEGF-D ANTIBODIES | 2020-02-27 |
20200062837 | ANTI-NGF COMPOSITIONS AND USE THEREOF | 2020-02-27 |
20200062838 | METHODS OF PREVENTING INFLAMMATION AND TREATING PAIN USING ANTI-NGF COMPOSITIONS | 2020-02-27 |
20200062839 | USE OF DIANHYDROGALACTITOL OR ANALOGS AND DERIVATIVES IN COMBINATION WITH VEGF INHIBITORS TO TREAT CANCER | 2020-02-27 |
20200062840 | Anti-IL31 Antibodies for Veterinary Use | 2020-02-27 |
20200062841 | Method for Treating Lupus By Administering An Anti-IL-12 Antibody | 2020-02-27 |
20200062842 | ANTIBODIES DIRECTED AGAINST SIGNAL PEPTIDES, METHODS AND USES THEREOF | 2020-02-27 |
20200062843 | ANTI-CD19 HUMANIZED ANTIBODY AND IMMUNE EFFECTOR CELL TARGETING CD19 | 2020-02-27 |
20200062844 | ANTI-FC EPSILON-R1 ALPHA (FCER1A) ANTIBODIES, BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND FCER1A AND CD3, AND USES THEREOF | 2020-02-27 |
20200062845 | COMBINATION OF ANTI-LAG-3 ANTIBODIES AND ANTI-PD-1 ANTIBODIES TO TREAT TUMORS | 2020-02-27 |
20200062846 | IMMUNOPOTENTIATIVE COMPOSITION | 2020-02-27 |
20200062847 | RECOMBINANT ANTIBODIES TO PROGRAMMED DEATH 1 (PD-1) AND USES THEREFOR | 2020-02-27 |
20200062848 | HUMAN MONOCLONAL ANTIBODIES TO PROGRAMMED DEATH LIGAND 1 (PD-L1) | 2020-02-27 |
20200062849 | COMBINATION PDL1 AND TGF-BETA BLOCKADE IN PATIENTS WITH HPV+ MALIGNANCIES | 2020-02-27 |
20200062850 | COMBINATION OF AN ANTI-VEGFR-2 ANTIBODY AND AN ANTI-PD-L1 ANTIBODY FOR THE TREATMENT OF CANCER | 2020-02-27 |
20200062851 | ACTIVATABLE ANTIBODIES AND METHODS OF USE THEREOF | 2020-02-27 |
20200062852 | Methods for Detecting 1,25-dihydroxyvitamin D and Related Antibodies | 2020-02-27 |
20200062853 | MULTISPECIFIC ANTIBODIES AGAINST CD40 AND CD137 | 2020-02-27 |
20200062854 | BISPECIFIC BINDING MOLECULES THAT ARE CAPABLE OF BINDING CD137 AND TUMOR ANTIGENS, AND USES THEREOF | 2020-02-27 |
20200062855 | COMPOSITIONS AND METHODS OF PROMOTING WOUND HEALING | 2020-02-27 |
20200062856 | Humanized Anti-TPBG Antibody, Preparation Method Therefor, Conjugate Thereof, and Applications | 2020-02-27 |
20200062857 | VARIANT TARGET BINDING AGENTS AND USES THEREOF | 2020-02-27 |
20200062858 | TRISPECIFIC ANTIGEN BINDING PROTEINS | 2020-02-27 |
20200062859 | Anti-TIGIT Antibodies | 2020-02-27 |
20200062860 | ANTIBODIES DIRECTED TO THE DELETION MUTANTS OF EPIDERMAL GROWTH FACTOR RECEPTOR AND USES THEREOF | 2020-02-27 |
20200062861 | GLYCOSYNTHASE VARIANTS FOR GLYCOPROTEIN ENGINEERING AND METHODS OF USE | 2020-02-27 |
20200062862 | METHODS AND COMPOSITIONS FOR PROGNOSIS, DIAGNOSIS, AND TREATMENT OF ADAM8-EXPRESSING CANCER | 2020-02-27 |
20200062863 | METHODS OF ADMINISTERING INHIBITORY ANTI-FACTOR XII/XIIA MONOCLONAL ANTIBODIES | 2020-02-27 |
20200062864 | THERMALLY INHIBITED STARCH AND STARCHY FLOURS | 2020-02-27 |
20200062865 | SPHERICAL CELLULOSE NANOPARTICLES AND PROCESS FOR PREPARATION THEREOF | 2020-02-27 |
20200062866 | Antibodies Targeted to Fungal Cell Wall Polysaccharides | 2020-02-27 |